|
GKAP1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62458935193399E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.5527136788005E-15 |
| Normal-vs-Stage2 |
4.3424999995878E-07 |
| Normal-vs-Stage3 |
4.44089209850063E-16 |
| Normal-vs-Stage4 |
1.7027490528676E-12 |
| Stage1-vs-Stage2 |
5.212400E-01 |
| Stage1-vs-Stage3 |
2.219500E-03 |
| Stage1-vs-Stage4 |
6.763100E-04 |
| Stage2-vs-Stage3 |
1.413580E-02 |
| Stage2-vs-Stage4 |
4.520500E-03 |
| Stage3-vs-Stage4 |
3.582200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
4.59149999998409E-06 |
| Normal-vs-Asian |
2.78280000154396E-08 |
| Caucasian-vs-AfricanAmerican |
7.365800E-01 |
| Caucasian-vs-Asian |
1.662950E-01 |
| AfricanAmerican-vs-Asian |
6.140200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.31050767196939E-13 |
| Normal-vs-Female |
1.62447832963153E-12 |
| Male-vs-Female |
9.444800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.6269208202857E-12 |
| Normal-vs-Age(41-60Yrs) |
1.10533804331681E-12 |
| Normal-vs-Age(61-80Yrs) |
1.66044955562938E-12 |
| Normal-vs-Age(81-100Yrs) |
2.88459999997492E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.731400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.632400E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.694000E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.773800E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.915500E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.049200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.28270000013353E-07 |
| Classical-VS-Follicular |
1.831830E-02 |
| Classical-VS-Other |
1.067370E-01 |
| Classical-VS-Normal |
1.62447832963153E-12 |
| Tall-VS-Follicular |
2.6101999450745E-09 |
| Tall-VS-Other |
9.018900E-03 |
| Tall-VS-Normal |
1.62436730732907E-12 |
| Follicular-VS-Other |
9.779800E-02 |
| Follicular-VS-Normal |
6.21800000377704E-08 |
| Other-VS-Normal |
4.184400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.29909449653587E-13 |
| Normal-vs-N1 |
3.76143560743003E-13 |
| N0-vs-N1 |
1.534420E-02 |
|
|
